Uncategorized


November 3, 2024

[DVA, FMS, ARDX, American Renal] CY25 Medicare Dialysis Rates Offer Slight Improvement, But More Material Policy Headwinds Remain

By Beth Steindecker

Key Takeaways:  CMS offered slight improvements in dialysis center payments, relative to this summer’s proposal, in its CY25 final rule released Friday, but we do not view this as material for providers or addressing other…

Read More >>

November 3, 2024

[AMED, EHAB, PNTG]: Final CY25 Medicare Home Health Rates In-Line and Foreshadow Future CMS Rate Pressures

By Beth Steindecker

Key Takeaways:  Changes to Medicare home health payments live up to expectations of a minimal increase, but with future negative adjustments following CMS’s release of its CY25 final rule Friday. As we wrote in mid-October,…

Read More >>

November 1, 2024

2024 Election: Our Final Call

By Joe Lieber

As we head into the last few days of the 2024 election, we continue to believe that former President Donald Trump has a slight edge over Vice President Kamala Harris. We see the Republicans picking…

Read More >>

October 31, 2024

Fiscal Policy and Deficits Post-Election Scenario

By Joe Lieber

We believe that the most bearish views on fiscal policy and deficit implications of the various election scenarios are unlikely to come to fruition. In short, even if the bond market doesn’t keep a check…

Read More >>

October 28, 2024

[BSX, MDT, LIVN, INSP, CVRX] Catalyst Watch: Medicare Rate Rule Prep Pack

By John Leppard

Key Takeaways: With CMS likely to release its final CY25 hospital outpatient payment rule by Friday (typically aftermarket) or early next week, we offer the following expectations for key product payment decisions, listed in market…

Read More >>

October 25, 2024

[THC, HCA, SGRY] Are the Winds of Medicare Site Neutrality Blowing Again?

By Beth Steindecker

Key Takeaways: The need for legislative savings to offset healthcare extenders during the lame duck puts a target on hospital outpatient departments (HOPDs) and ambulatory surgery centers (ASCs). While we doubt Congress will slash operators’…

Read More >>

October 24, 2024

Congressional Agenda and the Lame Duck Session

By Joe Lieber

While the main focus of the upcoming lame duck session, beginning Nov. 12, is for Congress to address a FY25 government funding bill, we count no fewer than 15 other issues impacting the financial markets…

Read More >>

October 23, 2024

Lantheus (LNTH): Pylarify Medicare Rate Expectations

By John Leppard

Key Takeaways: With CMS due to release its CY25 hospital outpatient rule ~Nov. 1, we expect it to finalize separate payments for diagnostic radiopharmaceuticals, though with slight odds to the impact being a ~45% reduction…

Read More >>

October 22, 2024

Potential Top Officials in a Trump Administration

By Joe Lieber

While the presidential race is basically a tossup, we recently moved our odds to slightly favor Trump (see note here). With that in mind, we offer a comprehensive list of potential candidates for key Cabinet…

Read More >>

October 21, 2024

Managed Care Policy Puts and Takes

By Beth Steindecker

Key Takeaways: We remain optimistic about the long-term policy outlook for the managed care industry, despite the puts and takes for different business lines associated with the outcome of the upcoming elections on Nov. 5….

Read More >>